RT @paulmaciocia: Super exciting to see this make it to clinic (after many COVID-related delays) and the AUTO4/LibraT1 study continues to r…
@McKnightLab_UO TRBC1/2 CAR-T in production for PTCL by Autolus - https://t.co/g4IzhTnJB4 don’t know state of the clinic trial though
RT @Naturepub: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy while pr…
Open Access UCL Research: Targeting T-cell receptor β-constant region for immunotherapy of T-cell malignancies https://t.co/Rzw9V48FXR
RT @DrMiguelPerales: Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies @Pulecyte #ImmunoOnc @N…
RT @DrMiguelPerales: Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies @Pulecyte #ImmunoOnc @N…
RT @DrMiguelPerales: Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies @Pulecyte #ImmunoOnc @N…
Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies @Pulecyte #ImmunoOnc @NatureMedicine https://t.co/VPuKe5oRvR
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies https://t.co/NTN2xvWCrn
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies https://t.co/P1ps29l04Z
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy while preserving sufficient normal T cells to maintain cellular immunity: https://t.co/UGRRsVycEc https://t.co/4uaxFes2mv
RT @mmw_lmw: Targeting #Tcell receptor #TCR b-chain for #Immunotherapy CAR-T therapy Tcell #lymphomas | MartinPule @UCL @NatureMedicine htt…
More info about #TCR and #CAR https://t.co/Jgc5pzCtQ8
RT @mmw_lmw: Targeting #Tcell receptor #TCR b-chain for #Immunotherapy CAR-T therapy Tcell #lymphomas | MartinPule @UCL @NatureMedicine htt…
RT @mmw_lmw: Targeting #Tcell receptor #TCR b-chain for #Immunotherapy CAR-T therapy Tcell #lymphomas | MartinPule @UCL @NatureMedicine htt…
RT @mmw_lmw: Targeting #Tcell receptor #TCR b-chain for #Immunotherapy CAR-T therapy Tcell #lymphomas | MartinPule @UCL @NatureMedicine htt…
RT @mmw_lmw: Targeting #Tcell receptor #TCR b-chain for #Immunotherapy CAR-T therapy Tcell #lymphomas | MartinPule @UCL @NatureMedicine htt…
RT @mmw_lmw: Targeting #Tcell receptor #TCR b-chain for #Immunotherapy CAR-T therapy Tcell #lymphomas | MartinPule @UCL @NatureMedicine htt…
RT @mmw_lmw: Targeting #Tcell receptor #TCR b-chain for #Immunotherapy CAR-T therapy Tcell #lymphomas | MartinPule @UCL @NatureMedicine htt…
RT @mmw_lmw: Targeting #Tcell receptor #TCR b-chain for #Immunotherapy CAR-T therapy Tcell #lymphomas | MartinPule @UCL @NatureMedicine htt…
Targeting #Tcell receptor #TCR b-chain for #Immunotherapy CAR-T therapy Tcell #lymphomas | MartinPule @UCL @NatureMedicine https://t.co/TvE2XoT2wC | News&Views @teresa_palomero AdolfoFerrando @Columbia https://t.co/PXtzKsqK4m https://t.co/XOAAZdLXVQ
RT @_mindfield: Another elegant approach to selectively target TRBC1+ T-cell lymphomas https://t.co/1xsVzdpebK
TCR-CAR. T-cell on T-cell #immunotherapy. https://t.co/GtTOFymfx8
Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies Nat Med 1113 https://t.co/onqmN9U4AZ
Spotlight: (Original article appears in @NatureMedicine https://t.co/jPgQdHepRv) https://t.co/DuQhxcmmCy
RT @mmw_lmw: #ImmunoTherapy for T cell Malignancies | AntiTCRb constant region #CAR_Tcells | MartinPule @ucl @NatureMedicine https://t.co/0…
RT @mmw_lmw: #ImmunoTherapy for T cell Malignancies | AntiTCRb constant region #CAR_Tcells | MartinPule @ucl @NatureMedicine https://t.co/0…
RT @mmw_lmw: #ImmunoTherapy for T cell Malignancies | AntiTCRb constant region #CAR_Tcells | MartinPule @ucl @NatureMedicine https://t.co/0…
RT @mmw_lmw: #ImmunoTherapy for T cell Malignancies | AntiTCRb constant region #CAR_Tcells | MartinPule @ucl @NatureMedicine https://t.co/0…
#ImmunoTherapy for T cell Malignancies | AntiTCRb constant region #CAR_Tcells | MartinPule @ucl @NatureMedicine https://t.co/0AqhJ7fr34 https://t.co/PpZ4F9EBqB
RT @celltherapynews: Targeting the T Cell Receptor β-Chain Constant Region for Immunotherapy of T Cell Malignancies @NatureMedicine @cardif…
RT @mmw_lmw: #ImmunoTherapy for T cell Malignancies | AntiTCRb constant region #CAR_Tcells | MartinPule @ucl @NatureMedicine https://t.co/3…
RT @celltherapynews: Targeting the T Cell Receptor β-Chain Constant Region for Immunotherapy of T Cell Malignancies @NatureMedicine @cardif…
RT @celltherapynews: Targeting the T Cell Receptor β-Chain Constant Region for Immunotherapy of T Cell Malignancies @NatureMedicine @cardif…
Targeting the T Cell Receptor β-Chain Constant Region for Immunotherapy of T Cell Malignancies @NatureMedicine @cardiffuni https://t.co/hENJ47BM2V https://t.co/byASrPkQfG
RT @mmw_lmw: #ImmunoTherapy for T cell Malignancies | AntiTCRb constant region #CAR_Tcells | MartinPule @ucl @NatureMedicine https://t.co/7…
RT @humanimmunenews: Targeting the T Cell Receptor β-Chain Constant Region for #Immunotherapy of T Cell Malignancies @NatureMedicine @ucl @…
RT @humanimmunenews: Targeting the T Cell Receptor β-Chain Constant Region for #Immunotherapy of T Cell Malignancies @NatureMedicine @ucl @…
Targeting the T Cell Receptor β-Chain Constant Region for #Immunotherapy of T Cell Malignancies @NatureMedicine @ucl @cardiffuni https://t.co/5Dg2igxaJa https://t.co/AcqwB5gX5c
Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies | Nature Medicine https://t.co/FmaRQfwJQN
Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies https://t.co/cXXr95LMzr
RT @mmw_lmw: #ImmunoTherapy for T cell Malignancies | AntiTCRb constant region #CAR_Tcells | MartinPule @ucl @NatureMedicine https://t.co/3…
RT @NatureMedicine: A new study finds that T cell receptor β-chain constant-targeted #immunotherapy could eradicate a T cell malignancy whi…
RT @mmw_lmw: #ImmunoTherapy for T cell Malignancies | AntiTCRb constant region #CAR_Tcells | MartinPule @ucl @NatureMedicine https://t.co/5…
RT @mmw_lmw: #ImmunoTherapy for T cell Malignancies | AntiTCRb constant region #CAR_Tcells | MartinPule @ucl @NatureMedicine https://t.co/5…
RT @mmw_lmw: #ImmunoTherapy for T cell Malignancies | AntiTCRb constant region #CAR_Tcells | MartinPule @ucl @NatureMedicine https://t.co/5…
RT @mmw_lmw: #ImmunoTherapy for T cell Malignancies | AntiTCRb constant region #CAR_Tcells | MartinPule @ucl @NatureMedicine https://t.co/5…